VolitionRx Announces Pricing of Underwritten Public Offering of Common Stock
VolitionRx Announces Proposed Underwritten Public Offering of Common Stock
VolitionRx To Present First Data on Nu.Q™ Capture Performance and Nu.Q™ Assay Performance in Lung Cancer and Blood Cancer at the 2020 ASCO Annual Meeting
VolitionRx Limited Announces First Quarter 2020 Financial Results and Business Update
VolitionRx Limited Schedules First Quarter 2020 Earnings Conference Call and Business Update
Volition's Nu.Q™ Vet Assay Detects Two Common Canine Cancers
Volition Files Patent for Nu.Q(TM) COVID-19 Triage Test and Commences Proof of Concept Studies
VolitionRx Limited Releases Annual Corporate Brochure and Video
VolitionRx Limited to Present at Conferences in March 2020
VolitionRx Limited Announces Full Fiscal Year 2019 Financial Results and Business Update
